Ranbaxy and Mylan unit to make and market three Gilead HIV drugs in developing countries
13 July 2011
Lupin may invest $50 million in Russian plant; Indian drugmakers doing well with ARVs
11 February 2011
J&J unit Tibotec signs multiple deals with generic drugmakers for access to new HIV treatment rilpivirine pre-approval
31 January 2011
Showing 1-4 of 4 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
